ÂÜÀòÂÒÂ×

Mark R. Rigby, MD, PhD, FAAP, FCCM, currently serves as the Executive Director of Immunology Clinical Development at AnaptysBio in San Diego. Previously, Mark held several prominent positions, including Senior Director of Clinical Development at Teva Pharmaceuticals and Vice President of Clinical Development at Provention Bio, where they led trials focusing on novel immune therapies. Mark's extensive academic background includes serving as Academic Chief of Pediatric Critical Care at Indiana University and faculty in Pediatric Critical Care and Transplant Immunology at Emory University. Mark completed their MD and PhD at the University of Massachusetts Medical School and their fellowship in Pediatric Critical Care at The Johns Hopkins University.